Thalidomide and Lenalidomide Extend Survival in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
暂无分享,去创建一个
Dong-Kug Choi | Susanne Petri | M. Beal | S. Petri | D. Choi | K. Hensley | C. Stewart | M. Kiaei | N. Calingasan | P. Schafer | G. Gárdián | M. Flint Beal | G. Muller | Mahmoud Kiaei | Khatuna Kipiani | Gabrielle Gardian | Junyu Chen | Noel Y. Calingasan | Peter Schafer | George W. Muller | Charles Stewart | Kenneth Hensley | K. Kipiani | Junyu Chen
[1] S. Nagata,et al. Apoptosis by Death Factor , 1997, Cell.
[2] R. Dantzer,et al. A new concept in neurodegeneration: TNFα is a silencer of survival signals , 2000, Trends in Neurosciences.
[3] J. Julien,et al. Minocycline Slows Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis , 2002, Neurobiology of Disease.
[4] A Hirano,et al. Neuropathology of ALS , 1996, Neurology.
[5] D. Green,et al. Tumor necrosis factor alpha up-regulates non-lymphoid Fas-ligand following superantigen-induced peripheral lymphocyte activation. , 2002, The Journal of biological chemistry.
[6] M. Gurney,et al. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. , 1998, Glia.
[7] M. Gurney,et al. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS , 1998 .
[8] V. Dixit,et al. Recent advances in tumor necrosis factor and CD40 signaling. , 1996, Current opinion in genetics & development.
[9] M. Beal,et al. Integrative role of cPLA2 with COX‐2 and the effect of non‐steriodal anti‐inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis , 2005, Journal of neurochemistry.
[10] A. Imperato,et al. Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice , 1997, Neuroscience Letters.
[11] D. Schiffer,et al. Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis , 1996, Journal of the Neurological Sciences.
[12] D. Green,et al. Fas and Fas ligand in gut and liver. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[13] J. Elliott. Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. , 2001, Brain research. Molecular brain research.
[14] M. Beal,et al. Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis , 2005, Experimental Neurology.
[15] Minh N. H. Nguyen,et al. Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: No requirement for proapoptotic interleukin‐1β in neurodegeneration , 2001, Annals of neurology.
[16] S. Przedborski,et al. Inducible Nitric Oxide Synthase Up‐Regulation in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis , 1999, Journal of neurochemistry.
[17] G. Rosoklija,et al. Increased expression of the pro‐inflammatory enzyme cyclooxygenase‐2 in amyotrophic lateral sclerosis , 2001, Annals of neurology.
[18] S. Nagata,et al. Fas ligand-induced apoptosis. , 1999, Annual review of genetics.
[19] G. Mora,et al. Circulating levels of tumour necrosis factor-α and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis , 2000, Neuroscience Letters.
[20] H. Gundersen,et al. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator , 1991, The Anatomical record.
[21] T. Siddique,et al. Molecular genetic basis of familial ALS , 1996, Neurology.
[22] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[23] B. Pettmann,et al. Fas/Tumor Necrosis Factor Receptor Death Signaling Is Required for Axotomy-Induced Death of Motoneurons In Vivo , 2003, The Journal of Neuroscience.
[24] G. Sobue,et al. Differential expression of inflammation‐ and apoptosis‐related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis , 2002, Journal of neurochemistry.
[25] D. Borchelt,et al. ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions , 1997, Neuron.
[26] L. Tartaglia,et al. Two TNF receptors. , 1992, Immunology today.
[27] K. Hensley,et al. Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. , 2002, Journal of neurochemistry.
[28] J. Julien,et al. Apoptotic death of neurons exhibiting peripherin aggregates is mediated by the proinflammatory cytokine tumor necrosis factor-α , 2001, The Journal of cell biology.
[29] P. Haslett,et al. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. , 1999, Journal of immunology.
[30] Hiroshi Nishimune,et al. Motoneuron Death Triggered by a Specific Pathway Downstream of Fas Potentiation by ALS-Linked SOD1 Mutations , 2002, Neuron.
[31] M. Fresno,et al. The role of tumour necrosis factor, interleukin 6, interferon-γ and inducible nitric oxide synthase in the development and pathology of the nervous system , 1998, Progress in Neurobiology.
[32] J. Morrison,et al. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[33] E. Feldman,et al. Neuroinflammation, COX-2, and ALS—a dual role? , 2004, Experimental Neurology.
[34] P. Ghezzi,et al. Tumor Necrosis Factor and Motoneuronal Degeneration: An Open Problem , 2002, Neuroimmunomodulation.
[35] M. Gurney,et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.
[36] P. Leigh,et al. Motor neuron disease. , 1994, Springer London.
[37] G. Kaplan,et al. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation , 1993, The Journal of experimental medicine.
[38] P. Stieg,et al. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. , 2000, Science.
[39] Angus G. Dalgleish,et al. The evolution of thalidomide and its IMiD derivatives as anticancer agents , 2004, Nature Reviews Cancer.
[40] D. Borchelt,et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria , 1995, Neuron.
[41] M. Bellomo,et al. Tumor necrosis factor is increased in the spinal cord of an animal model of motor neuron degeneration. , 1998, European cytokine network.